Adaptive Biotechnologies Corporation (ADPT)

NMS – Real Time Price. Currency in USD

13.63

+0.09 (0.66%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

277M

179M

170M

185M

Cost of goods sold

-83M

-82M

-98M

-79M

Gross Profit

194M

97M

72M

106M

Operating expenses (excl. COGS)

-251M

-250M

-274M

-305M

Operating Income

-57M

-153M

-202M

-198M

Non-operating income, total

-2M

-6M

-24M

-2M

Pretax income

-59M

-160M

-225M

-200M

Equity in earnings

Taxes

Non-controlling/minority interest

-42K

103K

54K

177K

After tax other income/expense

Net income before discontinued operations

-59M

-159M

-225M

-200M

Adaptive Biotechnologies Corporation (ADPT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Adaptive Biotechnologies Corporation (ADPT)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Adaptive Biotechnologies Corporation (ADPT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Adaptive Biotechnologies Corporation (ADPT)

Income Statement (Annual)

Income Statement (Annual)